Literature DB >> 24522549

Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease.

Georgia S Gaki1, Athanasios G Papavassiliou.   

Abstract

Parkinson's disease is the second most common neurodegenerative movement disorder; however, its etiology remains elusive. Nevertheless, in vivo observations have concluded that oxidative stress is one of the most common causes in the pathogenesis of Parkinson's disease. It is known that mitochondria play a crucial role in reactive oxygen species-mediated pathways, and several gene products that associate with mitochondrial function are the subject of Parkinson's disease research. The PTEN-induced kinase 1 (PINK1) protects cells from mitochondrial dysfunction and is linked to the autosomal recessive familial form of the disease. PINK1 is a key player in many signaling pathways engaged in mitophagy, apoptosis, or microglial inflammatory response and is induced by oxidative stress. Several proteins participate in mitochondrial networks, and they are associated with PINK1. The E3 ubiquitin ligase Parkin, the protease presenilin-associated rhomboid-like serine protease, the tyrosine kinase c-Abl, the protein kinase MARK2, the protease HtrA2, and the tumor necrosis factor receptor-associated protein 1 (TRAP1) provide different steps of control in protection against oxidative stress. Furthermore, environmental toxins, such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, have been identified as contributors to parkinsonism by increasing oxidative stress in dopaminergic neurons. The present review discusses the mechanisms and effects of oxidative stress, the emerging concept of the impact of environmental toxins, and a possible neuroprotective role of the antioxidant astaxanthin in various neurodegenerative disorders with particular emphasis in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24522549     DOI: 10.1007/s12017-014-8294-x

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  138 in total

Review 1.  Progress in Parkinson's disease-where do we stand?

Authors:  André Toulouse; Aideen M Sullivan
Journal:  Prog Neurobiol       Date:  2008-06-05       Impact factor: 11.685

2.  Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains.

Authors:  Rajeswara Babu Mythri; C Venkateshappa; G Harish; Anita Mahadevan; Uday B Muthane; T C Yasha; M M Srinivas Bharath; S K Shankar
Journal:  Neurochem Res       Date:  2011-04-12       Impact factor: 3.996

3.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

4.  Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease.

Authors:  Iwona Kurkowska-Jastrzebska; Tomasz Litwin; Ilona Joniec; Agnieszka Ciesielska; Adam Przybyłkowski; Andrzej Członkowski; Anna Członkowska
Journal:  Int Immunopharmacol       Date:  2004-10       Impact factor: 4.932

5.  Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation.

Authors:  E M Wexler; D H Geschwind; T D Palmer
Journal:  Mol Psychiatry       Date:  2007-10-30       Impact factor: 15.992

Review 6.  Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: possible pharmacological strategies.

Authors:  Tomohiro Nakamura; Stuart A Lipton
Journal:  Cell Calcium       Date:  2010-01-08       Impact factor: 6.817

Review 7.  Neurodegenerative diseases and oxidative stress.

Authors:  Kevin J Barnham; Colin L Masters; Ashley I Bush
Journal:  Nat Rev Drug Discov       Date:  2004-03       Impact factor: 84.694

8.  Oxidative Stress, DNA Damage, and c-Abl Signaling: At the Crossroad in Neurodegenerative Diseases?

Authors:  Stefania Gonfloni; Emiliano Maiani; Claudia Di Bartolomeo; Marc Diederich; Gianni Cesareni
Journal:  Int J Cell Biol       Date:  2012-06-18

9.  PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices.

Authors:  Jun Kim; Ji-Won Byun; Insup Choi; Beomsue Kim; Hey-Kyeong Jeong; Ilo Jou; Eunhye Joe
Journal:  Exp Neurobiol       Date:  2013-03-31       Impact factor: 3.261

10.  Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson's disease.

Authors:  Seema Gollamudi; Ashu Johri; Noel Y Calingasan; Lichuan Yang; Olivier Elemento; M Flint Beal
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

View more
  69 in total

1.  Neuroprotective Effect of the LRRK2 Kinase Inhibitor PF-06447475 in Human Nerve-Like Differentiated Cells Exposed to Oxidative Stress Stimuli: Implications for Parkinson's Disease.

Authors:  Miguel Mendivil-Perez; Carlos Velez-Pardo; Marlene Jimenez-Del-Rio
Journal:  Neurochem Res       Date:  2016-07-09       Impact factor: 3.996

Review 2.  α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease.

Authors:  Sushil K Singh; Aloke Dutta; Gyan Modi
Journal:  Future Med Chem       Date:  2017-06-20       Impact factor: 3.808

3.  Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease.

Authors:  Saurav Brahmachari; Saebom Lee; Sangjune Kim; Changqing Yuan; Senthilkumar S Karuppagounder; Preston Ge; Rosa Shi; Esther J Kim; Alex Liu; Donghoon Kim; Stephan Quintin; Haisong Jiang; Manoj Kumar; Seung Pil Yun; Tae-In Kam; Xiaobo Mao; Yunjong Lee; Deborah A Swing; Lino Tessarollo; Han Seok Ko; Valina L Dawson; Ted M Dawson
Journal:  Brain       Date:  2019-08-01       Impact factor: 13.501

4.  Carvedilol attenuates 6-hydroxydopamine-induced cell death in PC12 cells: involvement of Akt and Nrf2/ARE pathways.

Authors:  Lan Wang; Rikang Wang; Minghua Jin; Yingjuan Huang; Anmin Liu; Jian Qin; Meihui Chen; Shijun Wen; Rongbiao Pi; Wei Shen
Journal:  Neurochem Res       Date:  2014-06-21       Impact factor: 3.996

5.  Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell Line.

Authors:  Shaletha Holmes; Meharvan Singh; Chang Su; Rebecca L Cunningham
Journal:  Endocrinology       Date:  2016-05-11       Impact factor: 4.736

Review 6.  Disturbance of redox homeostasis as a contributing underlying pathomechanism of brain and liver alterations in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency.

Authors:  Guilhian Leipnitz; Carmen Regla Vargas; Moacir Wajner
Journal:  J Inherit Metab Dis       Date:  2015-06-04       Impact factor: 4.982

Review 7.  Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms.

Authors:  Arthi Kanthasamy; Huajun Jin; Adhithiya Charli; Anantharam Vellareddy; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

8.  Potent Protection Against MPP+-Induced Neurotoxicity via Activating Transcription Factor MEF2D by a Novel Derivative of Naturally Occurring Danshensu/Tetramethylpyrazine.

Authors:  Shengquan Hu; Liang Wang; Shinghung Mak; Zaijun Zhang; Daping Xu; Haitao Li; Yide Li; Yuanjia Hu; Simon Ming Yuen Lee; Yuqiang Wang; Yifan Han
Journal:  Neuromolecular Med       Date:  2016-06-08       Impact factor: 3.843

9.  Preferential Heme Oxygenase-1 Activation in Striatal Astrocytes Antagonizes Dopaminergic Neuron Degeneration in MPTP-Intoxicated Mice.

Authors:  Xiaofeng Xu; Ning Song; Ranran Wang; Hong Jiang; Junxia Xie
Journal:  Mol Neurobiol       Date:  2015-09-18       Impact factor: 5.590

10.  Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration.

Authors:  Saurav Brahmachari; Preston Ge; Su Hyun Lee; Donghoon Kim; Senthilkumar S Karuppagounder; Manoj Kumar; Xiaobo Mao; Joo Ho Shin; Yunjong Lee; Olga Pletnikova; Juan C Troncoso; Valina L Dawson; Ted M Dawson; Han Seok Ko
Journal:  J Clin Invest       Date:  2016-06-27       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.